Kalipso Chalkidou publications per year

The chart shows the history of publications by Kalipso Chalkidou between 2006 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Kalipso Chalkidou published across 20 years, from 2006 to 2025, averaging 11.3 papers a year. Output peaked at 33 publications in 2020. 5 of the 225 publications appeared in the last two years.

No. of publications

10 20 30

2006 2025

225 publications in total across all disciplines

View publications per year as a table

Kalipso Chalkidou: publications per year, 2006 to 2025
Year	Publications
2006	2
2007	6
2008	5
2009	12
2010	9
2011	7
2012	11
2013	6
2014	4
2015	8
2016	13
2017	16
2018	26
2019	24
2020	33
2021	20
2022	11
2023	7
2024	1
2025	4
Total	225

Download as CSV

Kalipso Chalkidou publication distribution in Economics and Finance in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Economics and Finance in 2026. The highlighted bar marks where Kalipso Chalkidou sits on this spectrum.

No. of scientists

25 50 75 100

42–46 publications 521+

This scientist: 187 publications — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 521 publications or more.

View publications distribution as a table

Number of Economics and Finance scientists by publication count, Research.com 2026 ranking edition. Based on 3,760 ranked scientists.
Publications	Scientists	This scientist
42–46	1
47–51	12
52–56	7
57–61	23
62–66	32
67–71	36
72–76	56
77–81	57
82–86	70
87–91	86
92–96	72
97–101	106
102–106	97
107–111	96
112–116	101
117–121	103
122–126	102
127–131	108
132–136	107
137–141	111
142–146	94
147–151	96
152–156	100
157–161	74
162–166	68
167–171	91
172–176	76
177–181	75
182–186	61
187–191	66	187
192–196	68
197–201	71
202–206	60
207–211	56
212–216	44
217–221	51
222–226	65
227–231	48
232–236	59
237–241	37
242–246	37
247–251	41
252–256	43
257–261	33
262–266	34
267–271	39
272–276	25
277–281	29
282–286	29
287–291	26
292–296	31
297–301	31
302–306	24
307–311	28
312–316	24
317–321	13
322–326	14
327–331	25
332–336	18
337–341	16
342–346	18
347–351	15
352–356	17
357–361	19
362–366	16
367–371	17
372–376	7
377–381	18
382–386	13
387–391	19
392–396	9
397–401	10
402–406	13
407–411	13
412–416	5
417–421	10
422–426	6
427–431	12
432–436	9
437–441	9
442–446	10
447–451	12
452–456	8
457–461	4
462–466	7
467–471	4
472–476	5
477–481	6
482–486	7
487–491	8
492–496	5
497–501	4
502–506	4
507–511	5
512–516	7
517–520	7
521+	99

Download as CSV

Kalipso Chalkidou D-index placement in Economics and Finance in 2026

The chart shows the D-index (discipline H-index) distribution of Economics and Finance scientists ranked by Research.com in 2026. The highlighted bar marks where Kalipso Chalkidou sits on this spectrum.

No. of scientists

50 100 150

30 D-Index 101+

This scientist: 40 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 101 D-Index or more.

View D-Index distribution as a table

Number of Economics and Finance scientists by D-index, Research.com 2026 ranking edition. Based on 3,760 ranked scientists.
D-Index	Scientists	This scientist
30	126
31	147
32	157
33	178
34	171
35	141
36	132
37	129
38	130
39	120
40	117	40
41	113
42	114
43	97
44	115
45	86
46	78
47	83
48	62
49	74
50	50
51	66
52	69
53	55
54	67
55	61
56	62
57	45
58	34
59	47
60	46
61	36
62	37
63	56
64	50
65	32
66	28
67	30
68	24
69	25
70	22
71	21
72	26
73	24
74	23
75	12
76	14
77	15
78	15
79	17
80	17
81	11
82	10
83	16
84	11
85	5
86	9
87	13
88	9
89	7
90	6
91	4
92	8
93	10
94	11
95	6
96	4
97	4
98	6
99	6
100	8
101+	100

Download as CSV

Best Publications

A pragmatic–explanatory continuum indicator summary (PRECIS): a tool to help trial designers

Kevin E. Thorpe;Merrick Zwarenstein;Andrew D. Oxman;Shaun Treweek

1837
Citations
Evidence for overuse of medical services around the world

Shannon Brownlee;Kalipso Chalkidou;Jenny Doust;Adam G Elshaug

1048
Citations
Protocol for the development of guidance for stakeholder engagement in health and healthcare guideline development and implementation

Jennifer Petkovic;Alison Riddle;Elie A. Akl;Joanne Khabsa

233
Citations
An Introduction to the Main Types of Economic Evaluations Used for Informing Priority Setting and Resource Allocation in Healthcare: Key Features, Uses, and Limitations.

Hugo C Turner;Rachel A Archer;Laura E Downey;Wanrudee Isaranuwatchai;Wanrudee Isaranuwatchai

204
Citations
Evidence-informed frameworks for cost-effective cancer care and prevention in low, middle, and high-income countries

Kalipso Chalkidou;Patricio Marquez;Preet K Dhillon;Yot Teerawattananon

196
Citations
Comparative effectiveness research and evidence-based health policy: experience from four countries

Kalipso Chalkidou;Sean Tunis;Ruth Lopert;Lise Rochaix

194
Citations
The role for pragmatic randomized controlled trials (pRCTs) in comparative effectiveness research

Kalipso Chalkidou;Sean Tunis;Danielle Whicher;Robert Fowler

184
Citations
Priority-setting for achieving universal health coverage

Kalipso Chalkidou;Amanda Glassman;Robert Marten;Jeanette Vega

183
Citations
Priority-Setting in Health: Building Institutions for Smarter Public Spending

Amanda Glassman;Kalipso Chalkidou

137
Citations
Searching for cost effectiveness thresholds in the NHS

John Appleby;John Appleby;Nancy Devlin;Nancy Devlin;David Parkin;Martin Buxton

132
Citations
The Use of Cost-Effectiveness Thresholds for Evaluating Health Interventions in Low- and Middle-Income Countries From 2015 to 2020: A Review

Joseph Kazibwe;Joseph Kazibwe;Adrian Gheorghe;Adrian Gheorghe;David Wilson;Francis Ruiz;Francis Ruiz

120
Citations
Priority-setting institutions in health: recommendations from a center for global development working group.

Amanda Glassman;Kalipso Chalkidou;Ursula Giedion;Yot Teerawattananon

111
Citations
Evidence-Based Decision Making: When Should We Wait For More Information?

Kalipso Chalkidou;Joanne Lord;Alastair Fischer;Peter Littlejohns

103
Citations
Distributional Cost-Effectiveness Analysis Comes of Age.

Richard Andrew Cookson;Susan Griffin;Ole F Norheim;Anthony J Culyer

95
Citations
Reflections on the evolution of health technology assessment in Europe.

Corinna Sorenson;Kalipso Chalkidou

74
Citations
Health Technology Assessment capacity development in low- and middle-income countries: Experiences from the international units of HITAP and NICE

Sripen Tantivess;Kalipso Chalkidou;Nattha Tritasavit;Yot Teerawattananon

72
Citations
Strengthening health technology assessment systems in the global south: a comparative analysis of the HTA journeys of China, India and South Africa

Kim MacQuilkan;Peter Baker;Laura Downey;Francis Ruiz

70
Citations
Developing institutions for cancer care in low-income and middle-income countries: from cancer units to comprehensive cancer centres.

Bhawna Sirohi;Kalipso Chalkidou;Kalipso Chalkidou;C S Pramesh;Benjamin O Anderson

69
Citations
Expensive Cancer Drugs: A Comparison between the United States and the United Kingdom

Ruth R. Faden;Kalipso Chalkidou;John Appleby;Hugh R. Waters

66
Citations
What next after GDP-based cost-effectiveness thresholds?

Y-Ling Chi;Mark Blecher;Kalipso Chalkidou;Kalipso Chalkidou;Anthony Culyer

63
Citations